By Josh White
Date: Tuesday 30 Apr 2024
(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support as it progressed towards securing longer-term funding.
The AIM-traded firm said the extension would enable it to maintain its focus on preparations for securing future funding.
Key terms...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news